UPDATE: Goldman Sachs Upgrades Intuitive Surgical to Buy on Improving Fundamentals

Goldman Sachs upgraded Intuitive Surgical

from Neutral to Buy and raised the price target from $591.00 to $715.00. Goldman Sachs commented, "ISRG shares have stalled out LTM (-100bp vs. SPX) as debate regarding future growth has intensified. Our diligence and reported results, however, suggest that fundamentals are improving and a path toward further revenue/EPS upside is once again emerging. We are raising our forecasts to reflect more significant adoption in general surgery as well as new tech add-ons to support mix upgrades." Intuitive Surgical closed at $561.25 on Thursday.